<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03737032</url>
  </required_header>
  <id_info>
    <org_study_id>PRO18040159</org_study_id>
    <secondary_id>R21MH117400</secondary_id>
    <nct_id>NCT03737032</nct_id>
  </id_info>
  <brief_title>Theta Burst Stimulation in Young Adults With Depression</brief_title>
  <official_title>Theta Burst Stimulation in Young Adults With Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erika Forbes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the proposed 2-year study, the investigators will conduct a within-subject,
      counterbalanced investigation using functional magnetic resonance imaging (fMRI) and
      transcranial magnetic stimulation (TMS) to examine the acute effects of theta-burst
      stimulation (TBS) on function in dorsomedial prefrontal cortex (dmPFC) in 35 young adults
      with depression (18-25 years, 50% female).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each participant will undergo 3 sessions of TMS, one each of continuous and intermittent
      TBS--with the goal of decreasing or increasing dmPFC responding, respectively--and one of
      sham TBS. Session order will be counterbalanced, with a double-blind approach to condition.
      Brain function, behavior, and mood will be assessed before and after each TBS session.
      Broadly, the investigators predict that inhibitory TBS to the dmPFC will enhance neural,
      behavioral, and subjective aspects of reward function by reducing dmPFC function and dmPFC
      connectivity with the ventral striatum (VS).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants will receive intermittent Theta Burst Stimulation (TBS), continuous TBS, and sham TBS mimicking stimulation, in randomized, double-blind order across three sessions.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The content of each TBS condition will be unknown to participants and to the research staff member conducting assessment of change neural, behavioral, and subjective response with TBS.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>fMRI-assessed brain function in the dorsomedial prefrontal cortex</measure>
    <time_frame>before and after TBS is administered (1 hour)</time_frame>
    <description>Change in functional magnetic resonance imaging (fMRI)-assessed blood oxygen-level-dependent (BOLD) response to monetary reward in the dorsomedial prefrontal cortex (dmPFC), the site to which TBS will be administered. Change will be computed as the difference before/after each TBS session, for a total of 3 sessions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fMRI-assessed dmPFC-VS functional connectivity</measure>
    <time_frame>before and after TBS is administered (1 hour)</time_frame>
    <description>Change in fMRI-assessed functional connectivity in response to monetary reward between the dmPFC and the ventral striatum. Change will be computed as the difference before/after each TBS session, for a total of 3 sessions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hedonic capacity</measure>
    <time_frame>before and after TBS is administered (1 hour)</time_frame>
    <description>Change in self-reported hedonic capacity measured with the Snaith Hamilton Pleasure Scale (14 item measure, with each item rated 1-4 and higher scores indicating greater experience of pleasure; yielding a total score between 14 and 56). Change will be computed as the difference before/after each TBS session, for a total of 3 sessions.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Intermittent, Continuous, Sham Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Intermittent theta burst stimulation, 2) Continuous theta burst stimulation, 3) Sham theta burst stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermittent, Sham, Continuous Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Intermittent theta burst stimulation, 2) Sham theta burst stimulation, 3) Continuous theta burst stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous, Intermittent, Sham Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Continuous theta burst stimulation, 2) Intermittent theta burst stimulation, 3) Sham theta burst stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous, Sham, Intermittent Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Continuous theta burst stimulation, 2) Sham theta burst stimulation, 3) Intermittent theta burst stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham, Intermittent, Continuous Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Sham theta burst stimulation, 2) Intermittent theta burst stimulation, 3) Continuous theta burst stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham, Continuous, Intermittent Order</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 sessions of theta burst stimulation administered in the following order: 1) Sham theta burst stimulation, 2) Continuous theta burst stimulation, 3) Intermittent theta burst stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intermittent Theta Burst Stimulation</intervention_name>
    <description>Theta Burst Stimulation, a form of Transcranial Magnetic Stimulation, will be applied to the dorsomedial prefrontal cortex. will include 600 pulses delivered in brief bursts of three pulses with a frequency of 50 Hz, at an intensity of 110% of resting motor threshold, and administered every 200 ms (5 Hz). Bursts will be delivered without interruption for a total duration of 40 seconds.</description>
    <arm_group_label>Continuous, Intermittent, Sham Order</arm_group_label>
    <arm_group_label>Continuous, Sham, Intermittent Order</arm_group_label>
    <arm_group_label>Intermittent, Continuous, Sham Order</arm_group_label>
    <arm_group_label>Intermittent, Sham, Continuous Order</arm_group_label>
    <arm_group_label>Sham, Continuous, Intermittent Order</arm_group_label>
    <arm_group_label>Sham, Intermittent, Continuous Order</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Theta Burst Stimulation</intervention_name>
    <description>Theta Burst Stimulation, a form of Transcranial Magnetic Stimulation, will be applied to the dorsomedial prefrontal cortex. will include 600 pulses delivered in brief bursts of three pulses with a frequency of 50 Hz, at an intensity of 110% of resting motor threshold, and administered every 200 ms (5 Hz). Bursts will be delivered during 2 second periods (10 bursts/period) interleaved with 8-second stimulation-free intervals, for a total duration of 190 seconds.</description>
    <arm_group_label>Continuous, Intermittent, Sham Order</arm_group_label>
    <arm_group_label>Continuous, Sham, Intermittent Order</arm_group_label>
    <arm_group_label>Intermittent, Continuous, Sham Order</arm_group_label>
    <arm_group_label>Intermittent, Sham, Continuous Order</arm_group_label>
    <arm_group_label>Sham, Continuous, Intermittent Order</arm_group_label>
    <arm_group_label>Sham, Intermittent, Continuous Order</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Theta Burst Stimulation</intervention_name>
    <description>For the sham of theta burst stimulation, the device providing Theta Burst Stimulation can be placed in the same position and turned on, creating a similar experience for the participant, without providing any neural stimulation. Sham TBS will be delivered with a Cool-B65 Active/Placebo Coil, which includes a sham setting, and MagLink research software.</description>
    <arm_group_label>Continuous, Intermittent, Sham Order</arm_group_label>
    <arm_group_label>Continuous, Sham, Intermittent Order</arm_group_label>
    <arm_group_label>Intermittent, Continuous, Sham Order</arm_group_label>
    <arm_group_label>Intermittent, Sham, Continuous Order</arm_group_label>
    <arm_group_label>Sham, Continuous, Intermittent Order</arm_group_label>
    <arm_group_label>Sham, Intermittent, Continuous Order</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • DSM-5 Diagnosis of Major Depressive Disorder, Persistent Depressive Disorder (Dysthymia),
        Other Specified Depressive Disorder, or Other Unspecified Depressive Disorder

        Exclusion Criteria:

          -  Bipolar disorder, substance dependence, or lifetime history of psychosis

          -  Neurological disorder (e.g., seizure disorder)

          -  Pregnant

          -  MRI contradictions: claustrophobia, permanent orthodontic devices, metal implants or
             other forms of metal in the body that cannot be removed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erika E Forbes, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erika E Forbes, Ph.D.</last_name>
    <phone>412-383-5438</phone>
    <email>forbese@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa M Nance, B.A.</last_name>
    <phone>412-624-4140</phone>
    <email>nancem@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Pittsburgh, Department of Psychiatry</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika E Forbes, Ph.D.</last_name>
      <phone>412-383-5438</phone>
      <email>forbese@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Fabio Ferrarelli, MD, Ph.D.</last_name>
      <phone>(412) 864-1668</phone>
      <email>ferrarellif@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Erika E Forbes, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Forbes EE, Dahl RE. Neural systems of positive affect: relevance to understanding child and adolescent depression? Dev Psychopathol. 2005 Summer;17(3):827-50. Review.</citation>
    <PMID>16262994</PMID>
  </reference>
  <reference>
    <citation>Damoiseaux JS, Rombouts SA, Barkhof F, Scheltens P, Stam CJ, Smith SM, Beckmann CF. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13848-53. Epub 2006 Aug 31.</citation>
    <PMID>16945915</PMID>
  </reference>
  <reference>
    <citation>Downar J, Daskalakis ZJ. New targets for rTMS in depression: a review of convergent evidence. Brain Stimul. 2013 May;6(3):231-40. doi: 10.1016/j.brs.2012.08.006. Epub 2012 Sep 7. Review.</citation>
    <PMID>22975030</PMID>
  </reference>
  <reference>
    <citation>Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med. 2017 Jan;23(1):28-38. doi: 10.1038/nm.4246. Epub 2016 Dec 5. Erratum in: Nat Med. 2017 Feb 7;23 (2):264.</citation>
    <PMID>27918562</PMID>
  </reference>
  <reference>
    <citation>Dunlop K, Gaprielian P, Blumberger D, Daskalakis ZJ, Kennedy SH, Giacobbe P, Downar J. MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder. J Vis Exp. 2015 Aug 11;(102):e53129. doi: 10.3791/53129.</citation>
    <PMID>26327307</PMID>
  </reference>
  <reference>
    <citation>Etkin A, Egner T, Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci. 2011 Feb;15(2):85-93. doi: 10.1016/j.tics.2010.11.004. Epub 2010 Dec 16. Review.</citation>
    <PMID>21167765</PMID>
  </reference>
  <reference>
    <citation>Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, Katovich K, Mehta H, Patenaude B, Ramakrishnan C, Kalanithi P, Etkin A, Knutson B, Glover GH, Deisseroth K. Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science. 2016 Jan 1;351(6268):aac9698. doi: 10.1126/science.aac9698.</citation>
    <PMID>26722001</PMID>
  </reference>
  <reference>
    <citation>Forbes EE, Dahl RE. Research Review: altered reward function in adolescent depression: what, when and how? J Child Psychol Psychiatry. 2012 Jan;53(1):3-15. doi: 10.1111/j.1469-7610.2011.02477.x. Epub 2011 Nov 28. Review.</citation>
    <PMID>22117893</PMID>
  </reference>
  <reference>
    <citation>Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry. 2009 Jan;166(1):64-73. doi: 10.1176/appi.ajp.2008.07081336. Epub 2008 Dec 1.</citation>
    <PMID>19047324</PMID>
  </reference>
  <reference>
    <citation>Fox MD, Buckner RL, Liu H, Chakravarty MM, Lozano AM, Pascual-Leone A. Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4367-75. doi: 10.1073/pnas.1405003111. Epub 2014 Sep 29.</citation>
    <PMID>25267639</PMID>
  </reference>
  <reference>
    <citation>Grossheinrich N, Rau A, Pogarell O, Hennig-Fast K, Reinl M, Karch S, Dieler A, Leicht G, Mulert C, Sterr A, Padberg F. Theta burst stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry. 2009 May 1;65(9):778-84. doi: 10.1016/j.biopsych.2008.10.029. Epub 2008 Dec 13.</citation>
    <PMID>19070834</PMID>
  </reference>
  <reference>
    <citation>Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010 Jan;35(1):4-26. doi: 10.1038/npp.2009.129. Review.</citation>
    <PMID>19812543</PMID>
  </reference>
  <reference>
    <citation>Hanlon CA, Dowdle LT, Austelle CW, DeVries W, Mithoefer O, Badran BW, George MS. What goes up, can come down: Novel brain stimulation paradigms may attenuate craving and craving-related neural circuitry in substance dependent individuals. Brain Res. 2015 Dec 2;1628(Pt A):199-209. doi: 10.1016/j.brainres.2015.02.053. Epub 2015 Mar 11. Review.</citation>
    <PMID>25770818</PMID>
  </reference>
  <reference>
    <citation>Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6.</citation>
    <PMID>15664172</PMID>
  </reference>
  <reference>
    <citation>Opie GM, Vosnakis E, Ridding MC, Ziemann U, Semmler JG. Priming theta burst stimulation enhances motor cortex plasticity in young but not old adults. Brain Stimul. 2017 Mar - Apr;10(2):298-304. doi: 10.1016/j.brs.2017.01.003. Epub 2017 Jan 4.</citation>
    <PMID>28089653</PMID>
  </reference>
  <reference>
    <citation>Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.</citation>
    <PMID>19833552</PMID>
  </reference>
  <reference>
    <citation>Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, Di Lazzaro V, Ferreri F, Fitzgerald PB, George MS, Hallett M, Lefaucheur JP, Langguth B, Matsumoto H, Miniussi C, Nitsche MA, Pascual-Leone A, Paulus W, Rossi S, Rothwell JC, Siebner HR, Ugawa Y, Walsh V, Ziemann U. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015 Jun;126(6):1071-1107. doi: 10.1016/j.clinph.2015.02.001. Epub 2015 Feb 10. Review.</citation>
    <PMID>25797650</PMID>
  </reference>
  <reference>
    <citation>Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995 Jul;167(1):99-103.</citation>
    <PMID>7551619</PMID>
  </reference>
  <reference>
    <citation>Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009 Aug 12;4(8):e6598. doi: 10.1371/journal.pone.0006598.</citation>
    <PMID>19672310</PMID>
  </reference>
  <reference>
    <citation>Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.</citation>
    <PMID>3397865</PMID>
  </reference>
  <reference>
    <citation>Zhang WN, Chang SH, Guo LY, Zhang KL, Wang J. The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies. J Affect Disord. 2013 Nov;151(2):531-9. doi: 10.1016/j.jad.2013.06.039. Epub 2013 Jul 12.</citation>
    <PMID>23856280</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Erika Forbes</investigator_full_name>
    <investigator_title>Professor of Psychiatry, Psychology, Pediatrics, &amp; Clinical and Translational Science</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>We will share all individual participant data (IPD) that underlie results in publications that report findings related to tests of our major hypotheses.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Data will become available after results of planned tests are published or 5 years after completion of data collection, whichever occurs first. Data will remain available for 5 years.</ipd_time_frame>
    <ipd_access_criteria>We will create procedures for other researchers to request data and will maintain quality assurance of data requests and data sharing. Researchers who share data will be affiliated and in good standing with academic institutions, will have current certification of training in responsible conduct of research, and will complete data requests describing the purpose of the project, the data requested, and the data analysis plan. Requests will be reviewed by the Principal Investigator and, if needed, other members of the research team. Criteria for sharing data will include characteristics described above, as well as scientific merit of the proposed use of data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

